Graf Susan E
Insider CIK 1577637 · EPZM Chief Business Officer · FNCH Director · AARD Director · CGON Director · NPSP VP,Corp Development & Strategy
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics, Inc | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 9,354 | — | $0 | 9,354 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 30,508 | — | $0 | 30,508 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 24,165 | — | $0 | 24,165 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2024-10-04 | 2024-10-07 | 15,600 | — | $0 | 15,600 | SEC↗ |
| FNCH Finch Therapeutics Group, | P Buy | 2023-06-09 | 2023-06-09 | 5,010 | $0.27 | $1.4K | 5,010 | SEC↗ |
| FNCH Finch Therapeutics Group, | A Award deriv | 2023-06-08 | 2023-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FNCH Finch Therapeutics Group, | A Award deriv | 2022-06-13 | 2022-06-15 | 44,843 | — | $0 | 44,843 | SEC↗ |
| FNCH Finch Therapeutics Group, | A Award deriv | 2021-04-23 | 2021-04-27 | 23,419 | — | $0 | 23,419 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-02-09 | 2018-02-13 | 106,344 | — | $0 | 106,344 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-02-08 | 2017-02-09 | 109,866 | — | $0 | 109,866 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-04-25 | 2016-04-26 | 178,642 | — | $0 | 178,642 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 11,874 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 41,289 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 11,577 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 2,893 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,905 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 4,761 | $46.00 | $219.0K | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 1,445 | — | $0 | 2,893 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 10,905 | — | $0 | 10,905 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-12 | 2015-02-20 | 484 | $45.85 | $22.2K | 4,761 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 1,445 | — | $0 | 5,245 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-10 | 2015-02-11 | 6,711 | — | $0 | 41,289 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2015-02-10 | 2015-02-11 | 6,711 | $45.87 | $307.8K | 3,800 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-10 | 2015-02-11 | 6,711 | $14.90 | $100.0K | 10,511 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-06-17 | 2014-06-19 | 5,788 | — | $0 | 11,577 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-06-17 | 2014-06-19 | 5,788 | — | $0 | 5,788 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-06-17 | 2014-06-19 | 1,988 | $33.10 | $65.8K | 3,800 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 4,338 | — | $0 | 4,338 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 11,874 | — | $0 | 11,874 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-06-17 | 2013-06-18 | 17,365 | — | $0 | 17,365 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-06-17 | 2013-06-18 | 48,000 | — | $0 | 48,000 | SEC↗ |